Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma-Reference-Cited by-同舟云学术

Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma

Published:2004-08 Issue: Volume:45 Page:S125-S127
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Kindler Hedy L

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Chemotherapy in malignant pleural mesothelioma: a review;Ong;J. Clin. Oncol.,1996

2. Malignant pleural mesothelioma;Kindler;Curr. Treat. Options Oncol.,2000

3. VEGF, VEGF type C, and their receptors play an important role in angiogenesis and lymphangiogensis in human malignant mesothelioma tumors;Ohta;Br. J. Cancer,1999

4. Vascular endothelial growth factor is an autocrine growth factor in malignant mesothelioma;Strizzi;J. Pathol.,2001

5. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma;Linder;Anticancer Res.,1998

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleural Tumors;Sabiston and Spencer Surgery of the Chest;2016

2. The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2014-04

3. Novel Induction Therapies for Pleural Mesothelioma;Seminars in Thoracic and Cardiovascular Surgery;2014

4. Dasatinib: An Anti-Tumour Agent via Src Inhibition;Current Drug Targets;2011-04-01

5. Novel Human Single Chain Antibody Fragments That Are Rapidly Internalizing Effectively Target Epithelioid and Sarcomatoid Mesotheliomas;Cancer Research;2011-03-31